Lung Cancer

From the largest one-year cancer death rate drop in the US to Supreme Court Justice Ruth Bader Ginsburg announcing she is cancer-free for a fourth time, here’s what is making the headlines in the cancer space this week.
 

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Ed Kim to better understand genomics in lung cancer.

Patients with lung cancer are encouraged to participate in the new modules that will capture data to help gain insights into their treatment path and treatment options.

When others assume that patients with lung cancer must have smoked to get the disease, this stigma can affect patient outcomes.
 

The Food and Drug Administration approved Tecentriq in combination with chemotherapy for the first-line treatment of adults with metastatic non-squamous non-small cell lung cancer without EGFR or ALK mutations.
 

The FDA accepted a supplemental biologics license application (sBLA) and granted a priority review to Imfinzi (durvalumab) for the treatment of patients with previously untreated extensive-stage small cell lung cancer (SCLC), according to AstraZeneca, the drug’s manufacturer.

There is plenty of scientific data about the physical challenges patients with cancer endure, but more is needed to address psychosocial issues.

Patient advocate and lung cancer survivor Nancy Cohen discusses living with stage 4 lung cancer.

Here’s a look at what’s inside our November 2019 Lung Cancer special issue.

How one mother learned that “broken hearts still beat.”